A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

NCT07559175 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Exocrine Pancreatic Insufficiency (EPI)
Cystic Fibrosis (CF)
Pancreatic Enzyme Abnormality
Pancreatic Diseases

Interventions

DRUG: NHS7108
DRUG: Zenpep®

Sponsor

Aimmune Nestlé Health Science US R&D, LLC

Collaborators

[object Object]